Efficacy and Safety of Sofosbuvir-Based Antiviral Therapy to Treat Hepatitis C Virus Infection After Kidney Transplantation-Reference-Cited by-同舟云学术

Efficacy and Safety of Sofosbuvir-Based Antiviral Therapy to Treat Hepatitis C Virus Infection After Kidney Transplantation

Published:2015-11-20 Issue:5 Volume:16 Page:1474-1479
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Kamar N.¹²³,Marion O.¹,Rostaing L.¹²³,Cointault O.¹,Ribes D.¹,Lavayssière L.¹,Esposito L.¹,Del Bello A.¹,Métivier S.⁴,Barange K.⁴,Izopet J.²³⁵,Alric L.³⁶⁷

Affiliation:

1. Department of Nephrology and Organ Transplantation; CHU Rangueil; Toulouse France

2. INSERM U1043; IFR-BMT, CHU Purpan; Toulouse France

3. Université Paul Sabatier; Toulouse France

4. Department of Hepatology and Gastroenterology; Toulouse France

5. Laboratory of Virology; CHU Purpan; Toulouse France

6. MR 152 IRD-Toulouse 3 University; Toulouse France

7. Internal Medicine-Digestive Department; CHU Purpan; Toulouse France

Funder

Gilead Sciences

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Reference26 articles.

1. Treatment of hepatitis C virus infection (HCV) after renal transplantation: Implications for HCV-positive dialysis patients awaiting a kidney transplant;Kamar;Transplantation,2006

2. Antiviral therapy (pegylated interferon and ribavirin) of hepatitis C in dialysis patients: Meta-analysis of clinical studies;Fabrizi;J Viral Hepat,2014

3. Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients;Rostaing;Transplantation,1995

4. Kidney disease: improving global outcomes (KDIGO);Kidney Int Suppl,2008

5. Long-term ribavirin therapy in hepatitis C virus-positive renal transplant patients: Effects on renal function and liver histology;Kamar;Am J Kidney Dis,2003

Cited by 178 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness of Kidney Transplantation From Donors at Increased Risk of Blood-borne Virus Infection Transmission;Transplantation;2023-08-21

2. Efficacy and Safety of Sofosbuvir and Ledipasvir for Hepatitis C in Kidney Transplant Recipients: A Single-center Retrospective Observational Study;Balkan Medical Journal;2023-05-10

3. Current Approach to Renal Transplantation Candidates and Potential Donors with Viral Hepatitis;PRILOZI;2023-03-01

4. Donor derived infections in kidney transplant;Disease-a-Month;2022-12

5. KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease;Kidney International;2022-12